Sanofi’s decision to sell its stake in Opella to CD&R navigates political scrutiny while focusing on innovation in pharmaceuticals and vaccines.
Sanofi’s decision to sell its stake in Opella to CD&R navigates political scrutiny while focusing on innovation in pharmaceuticals and vaccines.